+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biobanks Market - Global Forecast 2026-2032- Product Image
Biobanks Market - Global Forecast 2026-2032- Product Image
New

Biobanks Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 183 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082867
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biobanks market is entering a new phase, as advanced technologies and shifting stakeholder expectations transform biobanks into integrated platforms essential to medical research and the broader healthcare landscape. This evolution presents senior leaders with strategic opportunities to align operations, partnerships, and digital capabilities for sustained competitive advantage.

Market Snapshot: Biobanks Market Size and Growth Trajectory

The biobanks market is experiencing significant growth, expanding from USD 82.02 billion in 2025 to USD 89.72 billion in 2026. Projections indicate the market will reach USD 175.29 billion by 2032, achieving a CAGR of 11.45%. This upward trajectory is driven by sustained investment in advanced sample preservation technologies, digital infrastructure, and expanding service offerings. The market’s response to both operational and regulatory pressures has resulted in more robust industry standards and growing momentum for solutions that support both translational and clinical value.

Scope & Segmentation of the Biobanks Market

The biobanking ecosystem serves a dynamic range of stakeholders worldwide, with strategic investments and operational models varying across segments and regions. Key market components, services, and opportunities include:

  • Type: Disease-oriented biobanks target specific clinical specimens for focused research, while genomic-based models enable high-throughput nucleic acid processing. Population-based biobanks facilitate longitudinal cohort studies, and virtual biobanking leverages distributed specimen metadata for seamless digital access.
  • Component: Consumables demand rigorous quality control; equipment—encompassing incubators, centrifuges, monitoring, and temperature systems—varies by facility type and research focus. Specialized services span data management, analytics, and secure chain-of-custody transport.
  • Sample Type: Protocols are tailored for blood derivatives, cell lines, nucleic acids, and tissue samples, ensuring analytical reliability and regulatory compliance.
  • Application: Clinical diagnostics, personalized medicine, and therapeutics depend on traceable, high-integrity biospecimens. Research and gene editing applications require accessible and interoperable resources.
  • End User: Academic institutions prioritize long-term study cohorts and innovation; contract research and manufacturing firms deliver analytics at scale; hospitals offer annotated clinical specimens; pharmaceutical and biotech organizations apply sample data to discovery and validation objectives.
  • Regions: The Americas integrate biobanking with established clinical and biotechnology clusters; Europe, Middle East & Africa focus on cross-border collaboration and federated data models; Asia-Pacific capitalizes on scalable infrastructure and broad partnerships to address diverse population needs.
  • Key Technologies: Leading capabilities include advanced sample preservation, digital data management, laboratory information management systems, and virtual biobanking frameworks supporting all operational categories.

Key Takeaways for Senior Decision-Makers

  • Integration of automation and digitalization links biobank repositories to clinical and genomic datasets, amplifying translational research capabilities and operational efficiency.
  • Investments in quality assurance, provenance tracking, and secure data linkage are focusing on automated systems and robust chain-of-custody to safeguard sample integrity and optimize compliance processes.
  • Dynamic consent management and tiered access solutions are being adopted to balance donor privacy with expanded research use, strengthening stakeholder trust and regulatory alignment.
  • Strategic collaborations between academic, commercial, and clinical entities are broadening operational reach, reducing risks associated with early-stage projects, and fostering responsive, multi-institutional research environments.
  • Flexible infrastructure models—centralized and decentralized—allow organizations to meet distinct user needs and navigate varied regulatory conditions, supporting resilience and scalable operations.
  • Advanced digital frameworks and federated research models are facilitating compliant global data access, supporting growth while upholding strict privacy and ethical standards.

Tariff Impact and Supply Chain Adaptation

Recent changes to tariffs and global trade regulations have prompted biobank leaders to reassess procurement and supply chain models. Increased costs for specialized equipment and consumables are driving shifts toward diversified supplier networks, an emphasis on domestic sourcing, and longer-term service agreements. These factors influence storage strategy, with many organizations considering expanded virtual biobanking and process optimization to manage volatility in input costs, all while maintaining research continuity and regulatory adherence.

Methodology & Data Sources

This report draws on comprehensive interviews with senior stakeholders, detailed technology evaluations, and analysis of public domain literature. By capturing insights from directors, procurement leaders, and service providers, the research ensures a balanced perspective. Cross-sectional studies of biobank operations, supply chains, and governance models underpin all findings, validating their operational relevance.

Why This Report Matters

  • Delivers actionable intelligence for aligning infrastructure, digital systems, and supply chain strategies to current and future operational and policy challenges.
  • Prepares organizational leaders to navigate evolving consent requirements, governance changes, and regional regulatory landscapes while maintaining secure, ethical operations.
  • Equips stakeholders to build agile partnerships and flexible business models, supporting resilient growth and high translational value in an evolving market environment.

Conclusion: Pathways to Institutional Value

Sustainable growth in biobanking will depend on integrating advanced technology, strong governance, and collaborative partnerships. Institutions that successfully align these elements are best placed to realize lasting strategic value from biobank assets.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biobanks Market, by Type
8.1. Disease-Oriented Biobanks
8.2. Genomic-Based Biobanks
8.3. Population-Based Biobanks
8.4. Virtual Biobanks
9. Biobanks Market, by Component
9.1. Consumables
9.2. Equipment
9.2.1. Incubators & Centrifuges
9.2.2. Monitoring Systems
9.2.3. Temperature Control Systems
9.2.3.1. Cryogenic Storage Systems
9.2.3.2. Freezers & Refrigerators
9.2.3.3. Thawing Equipment
9.3. Services
9.3.1. Data Management
9.3.2. Sample Analysis
9.3.3. Storage & Processing
9.3.4. Transport
10. Biobanks Market, by Sample Type
10.1. Blood Derivatives
10.2. Cell Lines
10.3. Nucleic Acid
10.4. Tissues
11. Biobanks Market, by Application
11.1. Clinical Diagnostics
11.2. Personalized Medicine
11.3. Research
11.4. Therapeutics
11.4.1. Drug Development
11.4.2. Gene Editing
12. Biobanks Market, by End User
12.1. Academic Institutions
12.2. Contract Research & Manufacturing Organizations
12.3. Hospitals
12.4. Pharmaceutical & Biotech Companies
13. Biobanks Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Biobanks Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Biobanks Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Biobanks Market
17. China Biobanks Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Azenta Life Science
18.6. Becton, Dickinson and Company
18.7. BioLife Solutions Inc.
18.8. Charles River Laboratories International, Inc.
18.9. Cryoport Systems, LLC
18.10. Hamilton Company
18.11. Lonza Group Ltd.
18.12. Merck KGaA
18.13. Qiagen N.V.
18.14. STEMCELL Technologies
18.15. Tecan Trading AG
18.16. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOBANKS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED BIOBANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED BIOBANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOBANKS MARKET SIZE, BY DISEASE-ORIENTED BIOBANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED BIOBANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED BIOBANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOBANKS MARKET SIZE, BY GENOMIC-BASED BIOBANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED BIOBANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED BIOBANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOBANKS MARKET SIZE, BY POPULATION-BASED BIOBANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL BIOBANKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL BIOBANKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOBANKS MARKET SIZE, BY VIRTUAL BIOBANKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOBANKS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOBANKS MARKET SIZE, BY INCUBATORS & CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOBANKS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOBANKS MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOBANKS MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOBANKS MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOBANKS MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOBANKS MARKET SIZE, BY CRYOGENIC STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOBANKS MARKET SIZE, BY FREEZERS & REFRIGERATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOBANKS MARKET SIZE, BY FREEZERS & REFRIGERATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOBANKS MARKET SIZE, BY FREEZERS & REFRIGERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOBANKS MARKET SIZE, BY THAWING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOBANKS MARKET SIZE, BY THAWING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOBANKS MARKET SIZE, BY THAWING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOBANKS MARKET SIZE, BY DATA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOBANKS MARKET SIZE, BY STORAGE & PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOBANKS MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOBANKS MARKET SIZE, BY BLOOD DERIVATIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOBANKS MARKET SIZE, BY CELL LINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOBANKS MARKET SIZE, BY NUCLEIC ACID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOBANKS MARKET SIZE, BY TISSUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOBANKS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOBANKS MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOBANKS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOBANKS MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOBANKS MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOBANKS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOBANKS MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOBANKS MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOBANKS MARKET SIZE, BY CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOBANKS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIOBANKS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS BIOBANKS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 145. EUROPE BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. EUROPE BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 147. EUROPE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 148. EUROPE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 149. EUROPE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 151. EUROPE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. AFRICA BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 167. AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 168. AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 169. AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 170. AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 171. AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 172. AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 174. AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. ASEAN BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 188. ASEAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 189. ASEAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 190. ASEAN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 191. ASEAN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 192. ASEAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 193. ASEAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. ASEAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 195. ASEAN BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. GCC BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GCC BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 198. GCC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 199. GCC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 200. GCC BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 201. GCC BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 202. GCC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 203. GCC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. GCC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 205. GCC BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. BRICS BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. BRICS BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 218. BRICS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 219. BRICS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 220. BRICS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 221. BRICS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 222. BRICS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 223. BRICS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 224. BRICS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 225. BRICS BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. G7 BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 227. G7 BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 228. G7 BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 229. G7 BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 230. G7 BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 231. G7 BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 232. G7 BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 233. G7 BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. G7 BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 235. G7 BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. NATO BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. NATO BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 238. NATO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 239. NATO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 240. NATO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 241. NATO BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 242. NATO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 243. NATO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. NATO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 245. NATO BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 252. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 253. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 254. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 256. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. CHINA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 258. CHINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 259. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
TABLE 260. CHINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
TABLE 261. CHINA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
TABLE 262. CHINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 263. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 264. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. CHINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 266. CHINA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Biobanks market report include:
  • Acorn Biolabs Inc.
  • Anuva
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Life Science
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioIVT, LLC
  • BioKryo by L’AIR LIQUIDE S.A.
  • BioLife Solutions Inc.
  • BocaBio
  • Bruker Corporation
  • CELLIVIA 3 S.A.
  • Celltex Therapeutics Corporation
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBiotech by Swedish Orphan Biovitrum AB
  • Cureline, Inc
  • Firalis Group
  • Greiner Bio-One International GmbH
  • Hamilton Company
  • Hope Biosciences, LLC
  • Lonza Group Ltd.
  • LVL technologies GmbH & Co. KG.
  • Merck KGaA
  • Precision Cellular Storage Ltd.
  • ProteoGenex, Inc.
  • Provia Laboratories, Inc.
  • Qiagen N.V.
  • Standard BioTools Inc.
  • STEMCELL Technologies
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited

Table Information

Report AttributeDetails
No. of Pages183
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 89.72 Billion
Forecasted Market Value ( USD ) by 2032 $ 175.29 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Biobanks Global Market Insights 2026, Analysis and Forecast to 2031 - Product Image

Biobanks Global Market Insights 2026, Analysis and Forecast to 2031

  • Report
  • 105 Pages
  • Global
From
Biobank Management Systems Market - Global Strategic Business Report - Product Image

Biobank Management Systems Market - Global Strategic Business Report

  • Report
  • 287 Pages
  • Global
From
Biobanking Market Size, Share, Trends and Forecast by Specimen Type, Biobank Type, Application, End-User, and Region, 2025-2033 - Product Image

Biobanking Market Size, Share, Trends and Forecast by Specimen Type, Biobank Type, Application, End-User, and Region, 2025-2033

  • Report
  • 142 Pages
  • Global
From
Biobanks - Global Strategic Business Report - Product Image

Biobanks - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Biobanks Market Size, Share & Trends Analysis Report by Product & Services (LIMS, Biobanking Equipment), Biospecimen Type (Organs, Stem Cells), Biobanks Type (Real, Virtual), Application, and Region with Growth Forecasts, 2025-2030 - Product Image

Biobanks Market Size, Share & Trends Analysis Report by Product & Services (LIMS, Biobanking Equipment), Biospecimen Type (Organs, Stem Cells), Biobanks Type (Real, Virtual), Application, and Region with Growth Forecasts, 2025-2030

  • Report
  • 185 Pages
  • Global
From

About the Biobank Market

The Biobank market is a subset of the biotechnology industry that focuses on the collection, storage, and distribution of biological samples for research purposes. These samples can include human tissue, blood, and other bodily fluids, as well as plant and animal tissue. The biobank market is driven by the need for high-quality biological samples for research and development in the biotechnology industry. Biobanks are used to store and distribute biological samples for a variety of research purposes, including drug discovery, diagnostics, and personalized medicine. They are also used to store and distribute samples for clinical trials and epidemiological studies. The biobank market is highly competitive, with a number of companies offering services such as sample collection, storage, and distribution. Some of the major players in the market include Thermo Fisher Scientific, Qiagen, BioStorage Technologies, and Brooks Life Sciences. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.